Review
Differences in bioactivity between human insulin and insulin analogues approved for therapeutic use- compilation of reports from the past 20 years
-
* Corresponding author: Haim Werner hwerner@post.tau.ac.il
Diabetology & Metabolic Syndrome 2011, 3:13 doi:10.1186/1758-5996-3-13
Table 1
Doris Mayer (2011-12-19 12:34) German Cancer Research Center, Heidelberg
Please note that insulin signaling results in GSK-3 inactivation. GSK-3 is negatively regulated by phosphorylation.
Competing interests
None declared
top